Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3225
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05712538 | Safety, Tolerability, and Pharmacokinetics of ARCT-032 in Healthy Adult Subjects and Adults With Cystic Fibrosis. | ||
| NCT02500381 | Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) | ||
| NCT06937567 | CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors | ||
| NCT05028764 | Determine Range of Tissue Frataxin Concentrations and Other Potential Biomarkers | ||
| NCT03500263 | Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis | ||
| NCT01108549 | Treatment of Chronic Fatigue Syndrome and Fibromyalgia With D-ribose- a Multicenter Study | ||
| NCT04768881 | Safety and Efficacy of Selinexor in Combination With Pembrolizumab in Recurrent Advanced Melanoma | ||
| NCT06270719 | An Observational Study Comparing Delandistrogene Moxeparvovec With Standard of Care in Participants With Duchenne Muscular Dystrophy | ||
| NCT06938711 | A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer | ||
| NCT00780598 | Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML | ||
| NCT00739687 | Safety & Efficacy of ALT-711 (Alagebrium) in Chronic Heart Failure | ||
| NCT03041116 | Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants | ||
| NCT04697758 | Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema | ||
| NCT05417126 | Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease | ||
| NCT05893043 | A Study of Multiple Ascending Doses of GSBR-1290 in Japanese and Non-Japanese Healthy Participants | ||
| NCT04306900 | TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers | ||
| NCT02164006 | Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients | ||
| NCT01171326 | Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients | ||
| NCT02912793 | Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients | ||
| NCT04054921 | Safety Study for Beta Thalassemia Subjects on PTG-300 | ||
| NCT01781104 | Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation | ||
| NCT05525455 | TT-816 As Monotherapy or in Combination with a PD-1 Inhibitor in Patients with Advanced Cancers (SEABEAM) (MK3475-E88) | ||
| NCT03278028 | A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts | ||
| NCT05622058 | A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer | ||
| NCT04475926 | A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice | ||
| NCT01966419 | Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE) | ||
| NCT03229798 | Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002) | ||
| NCT02169804 | An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal | ||
| NCT04902781 | Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia | ||
| NCT02342067 | Pharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in Combination | ||
| NCT06081699 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants | ||
| NCT05635747 | A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB | ||
| NCT01254890 | Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome | ||
| NCT04184050 | Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001) | ||
| NCT06158620 | Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease | ||
| NCT04129580 | reSET-O RCT (Randomized Controlled Trial) | ||
| NCT03861403 | A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors | ||
| NCT04519476 | Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy. | ||
| NCT07198724 | ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer | ||
| NCT03081247 | To Assess the Efficacy and Safety of PT010 Compared to PT009 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease | ||
| NCT05613868 | TPN-101 in Aicardi-Goutières Syndrome (AGS) | ||
| NCT04123574 | A Pilot Study of BXCL701 in Patients With Pancreatic Cancer | ||
| NCT04036682 | A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer | ||
| NCT02357524 | Oritavancin on the Results of Multiple Coagulation Tests in Healthy Volunteers | ||
| NCT06297226 | Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT04072315 | Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/ | ||
| NCT01715168 | A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer | ||
| NCT04739423 | A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders | ||
| NCT02751359 | Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers | ||
| NCT05291091 | Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) |
